Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Harvard Business School
UBS
Boehringer Ingelheim
Queensland Health
Fuji
Merck
Fish and Richardson

Generated: August 16, 2018

DrugPatentWatch Database Preview

Manufacturing and formulation information for tradename: HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE

« Back to Dashboard

HYDRALAZINE HYDROCHLORIDE

CASRN: 304-20-1UNII: FD

Manufacturing Methods

<truncated in preview>

HYDROCHLOROTHIAZIDE

CASRN: 58-93-5UNII: 0J4

Manufacturing Methods

<truncated in preview>

RESERPINE

CASRN: 50-55-5UNII: 8B1

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Daiichi Sankyo
Deloitte
Merck
McKesson
UBS
Cipla
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.